You searched for "Ear"
Where is it?
Humans’ ability to process sound is a multi-faceted phenomenon. It is a marvel which likely changes through our ageing process and is influenced by a myriad of factors. This paper examines the particulars of the dimensions of sound processing –...
Are they just ignoring you?
The clarity of hearing in background noise, which is influenced by the signal-to-noise ratio, has been a much-debated topic over many years from various angles. This study looks at anaesthetised cats and, as cats are not commonly known for their...Meet Robyn our News & Events Co-ordinator
ROBYN COOPER, News & Events Co-ordinator. Robyn joined Pinpoint Scotland a few months ago and would be delighted to hear from you. If you have a course or conference...Audiology in this issue...Women in Leadership
Priya Carling, AuD, Director and Consultant Audiologist,Kent Hearing Ltd, UK. E: priya@Kenthearing.com Alex Griffiths-Brown, BSc(Hons), MRes, Audiologist,The Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury, UK. E: alex.griffiths-brown@nhs.net Twitter: @griffithsbrown1 I am going to start off this editorial by clarifying that...YCOHNS: over 30 years of supporting the next generation of ENT consultants
See also: Young ELS: a fresh voice and community for the next generation of laryngologists The Young Consultants in Otolaryngology and Head and Neck Surgery (YCOHNS) was established over 30 years ago by a group of young ENT consultants including...
Postop follow up of oral squamous cell carcinoma: a new protocol
Oral and oropharyngeal cancers together are the sixth most common malignancy in the world, with an increasing incidence of oral squamous cell carcinoma (OSCC). The recurrence rate of OSCC is reported to be approximately 10-26%. About two-thirds of all recurrent...
Immunotherapy – could it be cheaper?
Immunotherapy is the only treatment for allergy to alter the disease course. Limited data exist on direct and indirect costs of subcutaneous (SCIT) and sublingual (SLIT) immunotherapy in America. This article assesses the cost effectiveness worldwide of the two immunotherapies....
